Latest Otsuka Holdings News & Updates

See the latest news and media coverage for Otsuka. We track all announcements, press releases, and industry mentions in real time, all in one place.

Otsuka Holdings (Otsuka)

Global healthcare holding company

otsuka.com

Headquarters: Chiyoda-ku, Japan
Company type: Public company
Number of employees: 83–200
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about Otsuka Holdings (Otsuka)

In short: Otsuka reported strong H1 results, advanced key drug trials, and acquired Transcend Therapeutics.

Company announcements

Yesterday Otsuka

Otsuka announced its third-quarter earnings results and revised its performance forecast upward.

Sales increased by 12.3% to 2 trillion 42 billion yen. Lexapro and other products drove growth, and operating profit also increased significantly.

September 14 Otsuka

Otsuka announces results from a Phase III trial showing extended progression-free survival for its lung cancer treatment.

A significant median extension of six months was confirmed with zipertinib combination, to be presented at WCLC2026.

August 28 Otsuka

Otsuka signs virtual PPA with Sojitz to expand renewable energy

The joint venture will install distributed solar facilities generating 51 GWh annually, directly supporting the group's 2028 carbon reduction targets.

August 13 Otsuka

Otsuka's Phase III REZILIENT3 trial achieves primary endpoint

Combination of ziparelcinib and chemotherapy prolongs progression-free survival in first-line treatment of non-small cell lung cancer with EGFR exon 20 insertion mutations. Safety is manageable, and regulatory submission is planned following discussions with the FDA.

Media coverage

October 29 RTTNews

Otsuka Holdings 9M Results Rise; Lifts FY26 Earnings View, Backs Revenue Forecast; Stock Down

Otsuka Holdings Co. ( OTSKF ,4578.T), a Japanese Pharmaceutical firm, Friday reported that its profit for nine months of fiscal 2026 increased from last year...

October 27 note

Despite a 33.9% drop in Samsca/Jynarque, operating profit for the first half rose 17.3%. How did Otsuka Holdings (4578) make up for it?

In the first half of 2026, when sales of the flagship drug Samsca/Jynarque fell by 33.9%, Otsuka Holdings' operating profit increased by 17.3%. How did...

October 22 MarketScreener

Otsuka's VOYXACT Sustains Kidney Function in Phase 3 of Trial

Ionis, Otsuka ALS Drug Meets Main Goal in Phase 3 Trial, Improving Survival MT Sep. 22 Otsuka, Ionis' experimental ALS drug meets main goal in...

October 1 富途牛牛

Otsuka Subsidiary Initiates US NDA Submission for Lung Cancer Drug

Otsuka's(TYO:4578) wholly owned subsidiary, Taiho Pharmaceutical, initiated a U.S. New Drug Application submission for zipalertinib in combination with platin...

Never miss news about Otsuka

Track Otsuka and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Otsuka competitors & trending companies

Browse news for competitors to Otsuka and other trending companies.